Research output per year
Research output per year
Fingerprint
Dive into the research topics where Jacob Haaber Christensen is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Researchers
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Research output
-
Ibrutinib, lenalidomide, and rituximab in relapsed mantle cell lymphoma: Long-term follow-up of the Nordic Lymphoma Group MCL6 Philemon trial
Forsgren, E., Jørgensen, R. R. K., Bentzen, H., Riise, J., Haaber, J., Pasanen, A., Kuitunen, H., Wader, K. F., El-Galaly, T. C., Hutchings, M., Glimelius, I. & Jerkeman, M., Mar 2025, In: HemaSphere. 9, 3, 13 p., e70101.Research output: Contribution to journal › Journal article › Research › peer-review
Open AccessFile -
NOTCH1 Mutations Are Associated With Therapy-Resistance in Patients With B-Cell Lymphoma Treated With CD20xCD3 Bispecific Antibodies
Kyvsgaard, E. R., Grauslund, M., Sjø, L., Melchior, L. C., Grantzau, T. L., Gjerdrum, L. M. R., Trab, T., Andersen, L. S., Gang, A. O., Breinholt, M., Møller, M. B., Haaber Christensen, J., Larsen, T. S., Clausen, M. R., Riley, C. H., Niemann, C. U., Grønbæk, K., Hutchings, M. & Husby, S., Apr 2025, In: American Journal of Hematology. 100, 4, p. 712-716Research output: Contribution to journal › Comment/debate › Research › peer-review
Open Access -
NOTCH1 Mutations Are Associated With Therapy-Resistance in Patients With B-Cell Lymphoma Treated With CD20xCD3 Bispecific Antibodies
Kyvsgaard, E. R., Grauslund, M., Sjø, L., Melchior, L. C., Grantzau, T. L., Gjerdrum, L. M. R., Trab, T., Andersen, L. S., Gang, A. O., Breinholt, M., Møller, M. B., Haaber Christensen, J., Larsen, T. S., Clausen, M. R., Riley, C. H., Niemann, C. U., Grønbæk, K., Hutchings, M. & Husby, S., 2025, (E-pub ahead of print) In: American Journal of Hematology.Research output: Contribution to journal › Comment/debate › Research › peer-review
Open Access -
Risk of Cardiovascular Disease in Patients With Classical Hodgkin Lymphoma: A Danish Nationwide Register-Based Cohort Study
Godtfredsen, S. J., Yonis, H., Baech, J., Al-Hussainy, N. R., Riddersholm, S., Kober, L., Schou, M., Christensen, J. H., Hutchings, M., Dahl-Sørensen, R. B., Kamper, P., Dietrich, C. E., Andersen, M. P., Torp-Pedersen, C., Sogaard, P., El-Galaly, T. C. & Kragholm, K. H., Feb 2025, In: European Journal of Haematology. 114, 2, p. 343-352Research output: Contribution to journal › Journal article › Research › peer-review
Open AccessFile -
Acalabrutinib and Rituximab in Elderly Patients with Newly Diagnosed Mantle Cell Lymphoma Including a Matched Population-Based External Comparator- the Nordic Lymphoma Group NLG-MCL8 (ALTAMIRA) Phase II Trial
Jerkeman, M., Wader, K. F., Glimelius, I., Pasanen, A., Kim, W. S., Hansen, L. K., Riise, J., Hutchings, M., Elhussein, H. H., Niemann, C. U., Kragh Jørgensen, R. R., El-Galaly, T. C., Ehinger, M., Beiske, K., Amini, R.-M., Møller, M. B., Karjalainen-Lindsberg, M.-L. & Christensen, J. H., 5. Nov 2024, In: Blood. 144, Suppl. 1Research output: Contribution to journal › Conference abstract in journal › Research › peer-review
Activities
-
Subcutaneous Epcoritamab with Rituximab + Lenalidomide in Patients with Relapsed or Refractory Follicular Lymphoma:Phase 1/2 Trial Update
Falchi, L. (Lecturer), Abrisqueta, P. (Author), Nijland, M. (Author), Leppä, S. (Author), Hutchings, M. (Author), Holte, H. (Guest lecturer), Merryman, R. W. (Author), J. Lugtenburg, P. (Author), de Vos, S. (Author), Cheah, C. Y. (Author), Christensen, J. H. (Author), Arcaini, L. (Author), Drott, K. (Author), Hellström, M. (Author), Leslie, L. A. (Author), Vitolo, U. (Author), Rana, A. (Author), Abbas, A. (Author), Wang, L. (Author), Dinh, M. H. (Author) & Belada, D. (Author)
11. Dec 2022Activity: Talks and presentations › Conference presentations
-
Efficacy and Safety of Parsaclisib in Patients with Relapsed or Refractory Mantle Cell Lymphoma Not Previously Treated with a BTK Inhibitor: Primary Analysis from a Phase 2 Study (CITADEL-205)
Mehta, A. (Lecturer), Trneny, M. (Co-author), Walewski, J. (Co-author), Ribrag, V. (Co-author), Dartigeas, C. (Co-author), Christensen, J. H. (Guest lecturer), Pane, F. (Guest lecturer), Rodríguez, G. (Co-author), Taszner, M. (Co-author), Venugopal, P. (Co-author), Zilioli, V. R. (Co-author), Zheng, F. (Co-author), DeMarini, D. J. (Co-author), Jiang, W. (Co-author) & Zinzani, P. L. (Co-author)
12. Dec 2021Activity: Talks and presentations › Conference presentations
-
Subcutaneous Epcoritamab in Combination with R-CHOP in Patients with Previously Untreated High-Risk Diffuse Large B-Cell Lymphoma: Preliminary Results from a Phase 1/2 Trial
Belada, D. (Speaker), Christensen, J. H. (Co-author), Drott, K. (Co-author), Snauwaert, S. (Co-author), Brody, J. (Co-author), Narkhede, M. (Co-author), Offner, F. (Co-author), Elliott, B. (Co-author), Liu, T. (Co-author), Cota Stirner, M. (Co-author), Abbas, A. (Co-author), Falchi, L. (Co-author) & Roost Clausen, M. (Co-author)
11. Dec 2021Activity: Talks and presentations › Conference presentations
-
ECHELON-2 (NCT01777152), a randomised, double-blind, phase 3 study of brentuximab vedotin + CHP vs CHOP in previously untreated patients with CD30-positive peripheral T-cell lymphoma: 5-year results
Zinzani, P. L. (Guest lecturer), Morschhauser, F. (Speaker), Horwitz, S. M. (Co-author), O'Connor, O. A. (Co-author), Pro, B. (Co-author), Illidge, T. (Co-author), Advani, R. (Co-author), Bartlett, N. L. (Co-author), Christensen, J. H. (Co-author), Domingo-Domenech, E. (Co-author), Rossi, G. (Co-author), Kim, W. S. (Co-author), Feldman, T. A. (Co-author), Menne, T. (Co-author), Belada, D. (Co-author), Illés, Á. (Co-author), Tobinai, K. (Co-author), Tsukasaki, K. (Co-author), Yeh, S.-P. (Co-author), Shustov, A. R. (Co-author), Hüttmann, A. (Co-author), Savage, K. J. (Guest lecturer), Yuen, S. (Co-author), Iyer, S. P. (Co-author), Miao, H. (Co-author), Bunn, V. (Co-author), Fenton, K. (Co-author), Fanale, M. A. (Co-author), Puhlmann, M. (Co-author) & Trumper, L. (Guest lecturer)
10. Dec 2021Activity: Talks and presentations › Conference presentations
-
Subcutaneous Epcoritamab in Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia: Preliminary Results from the Epcore CLL-1 Trial.
Kater, A. P. (Speaker), Christensen, J. H. (Co-author), Bentzen, H. H. (Co-author), Niemann, C. U. (Co-author), Hutchings, M. (Co-author), Chen, J. (Co-author), Rios, M. (Co-author), Palenski, T. (Co-author), Li, T. (Co-author) & Mato, A. R. (Co-author)
Dec 2021Activity: Talks and presentations › Conference presentations
Press/Media
-
Overlæge om ECHO-studiet: Data blev oversolgt ved præsentationen på EHA
18/06/2024
1 Media contribution
Press/Media: Press / Media
-
Nu har hæmatologernes fase I-enhed i Odense endelig fået fysiske rammer
12/06/2024
1 Media contribution
Press/Media: Press / Media
-
Fra murstensløs model: Nu er fase 1-enheden i Odense helt på plads
10/06/2024
1 Media contribution
Press/Media: Press / Media